NUTF2: A Protein Implicated in Cellular Processes and Various Diseases

Target Name: NUTF2P4

NCBI ID: G128322

NUTF2P4

Other Name(s): nuclear transport factor 2 pseudogene 4 | Nuclear transport factor 2-like | LOC128322

NUTF2: A Protein Implicated in Cellular Processes and Various Diseases

Nuclear transport factor 2 (NUTF2) is a protein that plays a critical role in the transport of nuclear proteins in the cell. It is a member of the transport factor family 2, which includes proteins that transport various proteins across the nuclear membrane. NUTF2 is widely expressed in various tissues and cells, including muscle, heart, brain, and stem cells. It is also expressed in various diseases, including cancer.

One of the unique features of NUTF2 is its ability to interact with the transcription factor nuclear transport factor 2 (NUTF2), which is a protein that plays a critical role in the regulation of gene expression. This interaction between NUTF2 and NUTF2 has led to the hypothesis that NUTF2 may be a drug target or biomarker for various diseases.

NUTF2 has been shown to be involved in various cellular processes, including cell division, cell signaling, and DNA replication. It is a key protein for the transport of the transcription factor NUTF2, which is responsible for regulating the expression of genes that are important for cell growth and survival.

In addition to its role in gene expression, NUTF2 is also involved in the regulation of cellular processes that are important for the development and progression of cancer. Studies have shown that NUTF2 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. It is also involved in the regulation of the angiogenesis, which is the process by which cancer cells grow and spread to other parts of the body.

The interaction between NUTF2 and NUTF2 has also led to the hypothesis that NUTF2 may be a drug target or biomarker for various diseases. For example, NUTF2 has been shown to be involved in the regulation of the development and progression of various diseases, including cancer. It is also involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target or biomarker, NUTF2 is also an attractive target for research into the regulation of various cellular processes. Its involvement in the regulation of gene expression, cell signaling, and DNA replication makes it an important protein for the study of cellular processes that are important for the development and progression of various diseases.

Overall, NUTF2 is a protein that has significant implications for the study of cellular processes that are important for the development and progression of various diseases. Its interaction with NUTF2 and its involvement in the regulation of various cellular processes make it a potential drug target or biomarker for various diseases. Further research is needed to fully understand the role of NUTF2 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Nuclear Transport Factor 2 Pseudogene 4

The "NUTF2P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUTF2P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets